Jean Bidlack
Concepts (457)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Receptors, Opioid, kappa | 61 | 1986 | 7 |
Why?
| Receptors, Opioid | 52 | 1980 | 16 |
Why?
| Receptors, Opioid, mu | 61 | 1984 | 15 |
Why?
| Cyclazocine | 14 | 1985 | 2 |
Why?
| Morphinans | 19 | 1995 | 2 |
Why?
| Receptors, Opioid, delta | 28 | 1986 | 7 |
Why?
| Narcotic Antagonists | 20 | 1990 | 14 |
Why?
| Analgesics, Opioid | 18 | 1995 | 37 |
Why?
| Analgesics | 19 | 1992 | 47 |
Why?
| Benzeneacetamides | 13 | 1992 | 3 |
Why?
| Morphine | 22 | 1989 | 38 |
Why?
| Naltrexone | 16 | 1982 | 8 |
Why?
| Hydromorphone | 11 | 1990 | 5 |
Why?
| CHO Cells | 31 | 2002 | 65 |
Why?
| Animals | 125 | 1976 | 1032 |
Why?
| Cricetinae | 31 | 2002 | 130 |
Why?
| Structure-Activity Relationship | 28 | 1983 | 124 |
Why?
| Radioligand Assay | 18 | 1995 | 30 |
Why?
| beta-Endorphin | 12 | 1986 | 12 |
Why?
| Guanosine 5'-O-(3-Thiotriphosphate) | 10 | 2000 | 8 |
Why?
| Thymoma | 7 | 1993 | 7 |
Why?
| Morphine Derivatives | 11 | 1981 | 5 |
Why?
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 13 | 1993 | 4 |
Why?
| Cricetulus | 21 | 2004 | 39 |
Why?
| Brain | 27 | 1980 | 305 |
Why?
| Thymus Neoplasms | 5 | 1993 | 12 |
Why?
| Mice | 51 | 1983 | 623 |
Why?
| Enkephalins | 17 | 1986 | 14 |
Why?
| Immune System | 5 | 1995 | 43 |
Why?
| Mice, Inbred ICR | 19 | 1992 | 34 |
Why?
| Stereoisomerism | 14 | 1980 | 31 |
Why?
| Pyrrolidines | 15 | 1992 | 11 |
Why?
| Azocines | 3 | 1996 | 2 |
Why?
| T-Lymphocytes | 7 | 1987 | 182 |
Why?
| Binding, Competitive | 16 | 1984 | 109 |
Why?
| Ligands | 19 | 1982 | 116 |
Why?
| Protein Binding | 14 | 2001 | 256 |
Why?
| Dose-Response Relationship, Drug | 19 | 1993 | 431 |
Why?
| Pain Measurement | 15 | 1993 | 98 |
Why?
| GTP-Binding Proteins | 5 | 1992 | 47 |
Why?
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 19 | 1986 | 7 |
Why?
| Amides | 5 | 2001 | 28 |
Why?
| Lipopolysaccharides | 2 | 2006 | 98 |
Why?
| Cell Membrane | 23 | 1980 | 170 |
Why?
| Benzomorphans | 8 | 1986 | 2 |
Why?
| Drug Tolerance | 5 | 1992 | 26 |
Why?
| Adenylate Cyclase | 8 | 1993 | 24 |
Why?
| Substance-Related Disorders | 3 | 1996 | 96 |
Why?
| Tumor Cells, Cultured | 17 | 1988 | 233 |
Why?
| Naloxone | 13 | 1983 | 22 |
Why?
| Morphine Dependence | 3 | 1996 | 3 |
Why?
| Leukocytes, Mononuclear | 2 | 1998 | 67 |
Why?
| Narcotics | 9 | 1985 | 29 |
Why?
| Lymphocytes | 5 | 1992 | 142 |
Why?
| Xanthenes | 2 | 2006 | 8 |
Why?
| Antibodies, Monoclonal | 9 | 1983 | 242 |
Why?
| Cyclohexanes | 2 | 2006 | 15 |
Why?
| Male | 47 | 1985 | 1558 |
Why?
| Rats | 33 | 1980 | 532 |
Why?
| Analgesics, Non-Narcotic | 6 | 2001 | 21 |
Why?
| Guinea Pigs | 14 | 1986 | 77 |
Why?
| Transfection | 5 | 2002 | 237 |
Why?
| Pain | 5 | 1996 | 192 |
Why?
| Injections, Intraventricular | 11 | 1993 | 21 |
Why?
| Fumarates | 2 | 2005 | 15 |
Why?
| Cyclic AMP | 6 | 1980 | 90 |
Why?
| Alkanes | 1 | 2008 | 3 |
Why?
| Phenobarbital | 1 | 2008 | 19 |
Why?
| Substance Withdrawal Syndrome | 1 | 2008 | 24 |
Why?
| Humans | 44 | 1983 | 1858 |
Why?
| Kinetics | 15 | 1982 | 349 |
Why?
| Seizures | 1 | 2008 | 79 |
Why?
| Receptors, Nicotinic | 3 | 1981 | 15 |
Why?
| Interleukin-6 | 2 | 2006 | 146 |
Why?
| Guanine Nucleotides | 3 | 1988 | 13 |
Why?
| Lymphocyte Activation | 4 | 1990 | 137 |
Why?
| Receptors, G-Protein-Coupled | 2 | 2004 | 41 |
Why?
| Mitogens | 2 | 1987 | 31 |
Why?
| Acetamides | 2 | 1995 | 20 |
Why?
| Signal Transduction | 5 | 2004 | 313 |
Why?
| Protein Precursors | 1 | 2006 | 49 |
Why?
| Cattle | 10 | 1982 | 176 |
Why?
| Gene Expression | 2 | 2006 | 291 |
Why?
| Receptor Aggregation | 1 | 2004 | 9 |
Why?
| Enkephalin, D-Penicillamine (2,5)- | 9 | 1986 | 4 |
Why?
| Reaction Time | 6 | 1993 | 82 |
Why?
| Monocytes | 1 | 2006 | 124 |
Why?
| Ibogaine | 1 | 2003 | 1 |
Why?
| Formamides | 1 | 2003 | 4 |
Why?
| Time Factors | 7 | 1999 | 896 |
Why?
| Cocaine-Related Disorders | 2 | 2000 | 23 |
Why?
| Binding Sites | 11 | 1988 | 213 |
Why?
| Lymphoma | 3 | 1992 | 96 |
Why?
| Macrophages | 1 | 2006 | 148 |
Why?
| Phycoerythrin | 4 | 1995 | 6 |
Why?
| Thiazoles | 3 | 2004 | 50 |
Why?
| Corpus Striatum | 5 | 1993 | 48 |
Why?
| Spleen | 5 | 1984 | 129 |
Why?
| Molecular Structure | 7 | 1993 | 67 |
Why?
| Rats, Inbred Strains | 12 | 1985 | 170 |
Why?
| Recombinant Fusion Proteins | 1 | 2004 | 189 |
Why?
| Behavior, Animal | 3 | 1980 | 77 |
Why?
| Immunoglobulin Fab Fragments | 3 | 1986 | 23 |
Why?
| Genetic Vectors | 1 | 2004 | 139 |
Why?
| Flow Cytometry | 4 | 1998 | 216 |
Why?
| Drug Design | 5 | 1995 | 33 |
Why?
| Cocaine | 4 | 1996 | 33 |
Why?
| Sulfur Radioisotopes | 3 | 2003 | 24 |
Why?
| Cell Line | 9 | 1985 | 375 |
Why?
| Mice, Inbred C57BL | 8 | 1995 | 318 |
Why?
| B-Lymphocytes | 2 | 1989 | 134 |
Why?
| Pentazocine | 1 | 2000 | 2 |
Why?
| Cytochrome P-450 Enzyme System | 2 | 2010 | 33 |
Why?
| Phytohemagglutinins | 6 | 1987 | 25 |
Why?
| Cinnamates | 2 | 1993 | 10 |
Why?
| Macrophages, Peritoneal | 1 | 1999 | 12 |
Why?
| Drug Interactions | 4 | 1993 | 111 |
Why?
| Hydrocodone | 1 | 1999 | 1 |
Why?
| Tetrahydroisoquinolines | 2 | 2006 | 3 |
Why?
| Membranes | 4 | 1984 | 23 |
Why?
| Alkaloids | 2 | 1992 | 19 |
Why?
| Dipeptides | 2 | 2006 | 17 |
Why?
| GTP Phosphohydrolases | 3 | 1992 | 21 |
Why?
| Fluorescent Dyes | 2 | 1996 | 115 |
Why?
| Calcium | 3 | 1987 | 210 |
Why?
| Concanavalin A | 5 | 1987 | 25 |
Why?
| Opioid Peptides | 2 | 1994 | 2 |
Why?
| Molecular Conformation | 5 | 2004 | 31 |
Why?
| Neuroimmunomodulation | 1 | 1998 | 7 |
Why?
| Down-Regulation | 4 | 1992 | 150 |
Why?
| Leukopoiesis | 1 | 1998 | 6 |
Why?
| Cyclic GMP | 1 | 1998 | 30 |
Why?
| Adenylate Cyclase Toxin | 2 | 1993 | 4 |
Why?
| Pertussis Toxin | 2 | 1993 | 25 |
Why?
| Virulence Factors, Bordetella | 2 | 1993 | 22 |
Why?
| Enkephalin, Leucine | 4 | 1985 | 4 |
Why?
| Furans | 2 | 2003 | 2 |
Why?
| T-Lymphocyte Subsets | 1 | 1998 | 70 |
Why?
| Neuroblastoma | 6 | 1983 | 36 |
Why?
| Bridged Compounds | 1 | 1996 | 1 |
Why?
| Spinal Cord | 1 | 1998 | 94 |
Why?
| Peptide Fragments | 4 | 1990 | 145 |
Why?
| Nerve Tissue | 2 | 1984 | 7 |
Why?
| Leukocytes | 1 | 1997 | 94 |
Why?
| Nitric Oxide | 1 | 1998 | 85 |
Why?
| Enzyme Inhibitors | 5 | 2000 | 216 |
Why?
| Neurons | 4 | 1980 | 195 |
Why?
| Oligopeptides | 3 | 1989 | 57 |
Why?
| Guanosine Triphosphate | 3 | 1988 | 22 |
Why?
| Rats, Sprague-Dawley | 4 | 1995 | 257 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 1999 | 104 |
Why?
| Alprostadil | 2 | 1990 | 7 |
Why?
| Disulfides | 1 | 1994 | 18 |
Why?
| Enkephalin, Methionine | 2 | 1987 | 3 |
Why?
| Sulfhydryl Compounds | 1 | 1994 | 42 |
Why?
| Tritium | 4 | 1992 | 65 |
Why?
| Protein Kinase C | 2 | 1990 | 93 |
Why?
| Conditioning, Operant | 2 | 2002 | 17 |
Why?
| Alkylation | 4 | 1989 | 7 |
Why?
| Enkephalin, Leucine-2-Alanine | 5 | 1985 | 2 |
Why?
| Phospholipase C beta | 3 | 1999 | 10 |
Why?
| Fluorescein-5-isothiocyanate | 3 | 1995 | 16 |
Why?
| Hydrophobic and Hydrophilic Interactions | 3 | 2006 | 13 |
Why?
| Discrimination Learning | 2 | 2002 | 20 |
Why?
| Self Administration | 3 | 1996 | 14 |
Why?
| Butorphanol | 2 | 2008 | 1 |
Why?
| Dithiothreitol | 4 | 1989 | 15 |
Why?
| Cell Line, Tumor | 2 | 2004 | 209 |
Why?
| Immunoglobulin M | 3 | 1985 | 82 |
Why?
| Phenazocine | 2 | 1988 | 1 |
Why?
| Peptides | 3 | 1995 | 154 |
Why?
| Ethylketocyclazocine | 3 | 1985 | 1 |
Why?
| Guanylyl Imidodiphosphate | 4 | 1988 | 3 |
Why?
| Decanoates | 1 | 2011 | 2 |
Why?
| Chemistry, Pharmaceutical | 2 | 2006 | 17 |
Why?
| Fluorescent Antibody Technique, Indirect | 4 | 1996 | 36 |
Why?
| Cimetidine | 1 | 2011 | 10 |
Why?
| Sarcoplasmic Reticulum | 2 | 1980 | 21 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2006 | 210 |
Why?
| Glycopeptides | 1 | 2010 | 9 |
Why?
| Esters | 1 | 2010 | 20 |
Why?
| Sodium | 2 | 1988 | 96 |
Why?
| Nicotine | 2 | 1980 | 19 |
Why?
| Sodium Chloride | 4 | 1988 | 77 |
Why?
| HIV-1 | 3 | 1996 | 93 |
Why?
| Gene Expression Regulation | 3 | 1999 | 279 |
Why?
| Microglia | 2 | 1996 | 29 |
Why?
| Levorphanol | 2 | 1981 | 2 |
Why?
| Hemolytic Plaque Technique | 1 | 1989 | 6 |
Why?
| Affinity Labels | 4 | 1982 | 17 |
Why?
| Cyclization | 1 | 2008 | 4 |
Why?
| Drug Evaluation, Preclinical | 2 | 2006 | 65 |
Why?
| Tramadol | 1 | 2008 | 3 |
Why?
| Myocardium | 2 | 1980 | 119 |
Why?
| Inositol Phosphates | 1 | 2008 | 19 |
Why?
| Piracetam | 1 | 2008 | 3 |
Why?
| Triazines | 1 | 2008 | 20 |
Why?
| Immunoglobulin Fragments | 1 | 1988 | 13 |
Why?
| Crystallography, X-Ray | 1 | 2009 | 41 |
Why?
| Half-Life | 1 | 2008 | 69 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 2001 | 113 |
Why?
| Extracellular Space | 1 | 2008 | 58 |
Why?
| Amino Acid Sequence | 6 | 1990 | 319 |
Why?
| Food | 2 | 2002 | 15 |
Why?
| Nalbuphine | 1 | 2007 | 2 |
Why?
| Immunosuppressive Agents | 1 | 1989 | 103 |
Why?
| Oxazoles | 1 | 2007 | 8 |
Why?
| Neostriatum | 2 | 1995 | 20 |
Why?
| Data Collection | 1 | 2008 | 137 |
Why?
| Anticonvulsants | 1 | 2008 | 61 |
Why?
| Basal Ganglia | 1 | 2008 | 23 |
Why?
| Carbamates | 1 | 2007 | 9 |
Why?
| Urea | 1 | 2007 | 31 |
Why?
| Macaca mulatta | 4 | 1996 | 71 |
Why?
| Indoles | 1 | 2007 | 69 |
Why?
| Gene Amplification | 2 | 1995 | 22 |
Why?
| U937 Cells | 1 | 2006 | 16 |
Why?
| Biotin | 2 | 1995 | 14 |
Why?
| Dactinomycin | 1 | 2006 | 40 |
Why?
| Molecular Weight | 5 | 1980 | 155 |
Why?
| Brain Chemistry | 3 | 1981 | 60 |
Why?
| Magnetic Resonance Spectroscopy | 3 | 1996 | 74 |
Why?
| Fluoresceins | 2 | 1995 | 50 |
Why?
| Chromatography, Affinity | 4 | 1981 | 49 |
Why?
| Cells, Cultured | 5 | 1991 | 447 |
Why?
| Prolactin | 1 | 2005 | 26 |
Why?
| Phenotype | 2 | 1998 | 304 |
Why?
| GTP-Binding Protein beta Subunits | 1 | 2006 | 10 |
Why?
| Receptors, Virus | 1 | 2005 | 19 |
Why?
| GTP-Binding Protein gamma Subunits | 1 | 2006 | 10 |
Why?
| Cerebellum | 1 | 1986 | 59 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2001 | 243 |
Why?
| Receptors, Chemokine | 1 | 2005 | 24 |
Why?
| Blotting, Northern | 1 | 2006 | 152 |
Why?
| Reward | 1 | 2004 | 11 |
Why?
| Opioid-Related Disorders | 2 | 1992 | 13 |
Why?
| Molecular Sequence Data | 6 | 1990 | 404 |
Why?
| RNA Stability | 1 | 2006 | 38 |
Why?
| Fluorescent Antibody Technique | 2 | 1995 | 164 |
Why?
| Herpesvirus 6, Human | 1 | 2005 | 22 |
Why?
| Viral Proteins | 1 | 2005 | 71 |
Why?
| Phenols | 1 | 2004 | 20 |
Why?
| Cell Survival | 1 | 2006 | 230 |
Why?
| Luminescent Proteins | 1 | 2004 | 67 |
Why?
| Adenoviridae | 1 | 2004 | 60 |
Why?
| Type C Phospholipases | 2 | 1999 | 34 |
Why?
| Endorphins | 3 | 1987 | 15 |
Why?
| Green Fluorescent Proteins | 1 | 2004 | 105 |
Why?
| Virus Replication | 3 | 1996 | 90 |
Why?
| Up-Regulation | 2 | 2001 | 183 |
Why?
| Transcription, Genetic | 2 | 1996 | 253 |
Why?
| Receptors, Cholinergic | 1 | 1983 | 15 |
Why?
| Buprenorphine | 1 | 2002 | 4 |
Why?
| Dimerization | 1 | 2003 | 92 |
Why?
| Isoenzymes | 3 | 1976 | 144 |
Why?
| Patch-Clamp Techniques | 1 | 2003 | 47 |
Why?
| Promoter Regions, Genetic | 1 | 2006 | 188 |
Why?
| Mass Spectrometry | 2 | 1996 | 57 |
Why?
| RNA, Messenger | 3 | 1996 | 394 |
Why?
| Calcium-Binding Proteins | 1 | 1982 | 49 |
Why?
| Female | 6 | 1996 | 1646 |
Why?
| Glioma | 3 | 1983 | 51 |
Why?
| Adenosine Triphosphatases | 1 | 1982 | 43 |
Why?
| Drug Combinations | 1 | 2001 | 96 |
Why?
| Electric Organ | 1 | 1980 | 4 |
Why?
| Multiple Sclerosis | 3 | 1985 | 43 |
Why?
| Hot Temperature | 2 | 1980 | 93 |
Why?
| Protein Kinases | 1 | 1980 | 64 |
Why?
| Solubility | 3 | 1981 | 76 |
Why?
| Muscle Proteins | 1 | 1980 | 56 |
Why?
| Neurons, Afferent | 1 | 1999 | 48 |
Why?
| Ion Transport | 1 | 1999 | 42 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2001 | 91 |
Why?
| Acetic Acid | 2 | 1993 | 10 |
Why?
| Trypsin | 3 | 1980 | 63 |
Why?
| Temperature | 2 | 1990 | 137 |
Why?
| Etorphine | 2 | 1981 | 1 |
Why?
| Antigens, CD8 | 1 | 1998 | 25 |
Why?
| NG-Nitroarginine Methyl Ester | 1 | 1998 | 23 |
Why?
| Antigens, CD3 | 1 | 1998 | 37 |
Why?
| Antigens, CD4 | 1 | 1998 | 29 |
Why?
| Dynorphins | 2 | 1993 | 7 |
Why?
| Nociceptors | 1 | 1997 | 14 |
Why?
| Fluorescein | 1 | 1997 | 18 |
Why?
| Thymus Gland | 1 | 1998 | 57 |
Why?
| Enzyme Activation | 2 | 1992 | 177 |
Why?
| Models, Chemical | 2 | 2006 | 57 |
Why?
| Fentanyl | 1 | 1996 | 13 |
Why?
| Models, Molecular | 3 | 1994 | 102 |
Why?
| Spectrometry, Fluorescence | 1 | 1997 | 59 |
Why?
| Lepidoptera | 1 | 1976 | 4 |
Why?
| Moths | 1 | 1976 | 16 |
Why?
| L-Lactate Dehydrogenase | 1 | 1976 | 59 |
Why?
| Hydrolysis | 2 | 1980 | 57 |
Why?
| Middle Aged | 2 | 1985 | 1166 |
Why?
| Tosylphenylalanyl Chloromethyl Ketone | 1 | 1994 | 5 |
Why?
| Muscles | 1 | 1976 | 111 |
Why?
| Ethylmaleimide | 1 | 1994 | 9 |
Why?
| Thyroid Neoplasms | 1 | 1995 | 43 |
Why?
| Mice, Inbred BALB C | 3 | 1983 | 176 |
Why?
| Reinforcement Schedule | 2 | 2002 | 11 |
Why?
| Dihydromorphine | 2 | 1981 | 2 |
Why?
| Sepharose | 1 | 1993 | 13 |
Why?
| Hybridomas | 2 | 1983 | 31 |
Why?
| Acetic Acids | 1 | 1993 | 31 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2004 | 68 |
Why?
| Chloroquine | 1 | 1992 | 16 |
Why?
| Peptide Library | 2 | 1998 | 21 |
Why?
| Staurosporine | 1 | 1992 | 24 |
Why?
| Mice, Knockout | 2 | 1999 | 265 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1992 | 83 |
Why?
| Deoxycholic Acid | 2 | 1980 | 7 |
Why?
| Microsomes | 2 | 1980 | 27 |
Why?
| Miconazole | 1 | 2011 | 1 |
Why?
| Receptors, Histamine H3 | 1 | 2011 | 1 |
Why?
| 14-alpha Demethylase Inhibitors | 1 | 2011 | 1 |
Why?
| NADPH-Ferrihemoprotein Reductase | 1 | 2011 | 5 |
Why?
| Sulfides | 1 | 2011 | 10 |
Why?
| Cell Line, Transformed | 1 | 2011 | 52 |
Why?
| Cerebrospinal Fluid | 2 | 1985 | 23 |
Why?
| Imidazoles | 1 | 2011 | 47 |
Why?
| Dogs | 2 | 1980 | 159 |
Why?
| Phospholipids | 2 | 1980 | 52 |
Why?
| Alkylating Agents | 1 | 1990 | 15 |
Why?
| Sulfhydryl Reagents | 1 | 1990 | 14 |
Why?
| Sensitivity and Specificity | 1 | 1993 | 427 |
Why?
| Guanosine Diphosphate | 1 | 1989 | 9 |
Why?
| Cations | 1 | 1989 | 19 |
Why?
| Antigens, Heterophile | 1 | 1989 | 2 |
Why?
| Base Sequence | 3 | 1990 | 371 |
Why?
| Hybrid Cells | 1 | 1989 | 16 |
Why?
| Blood Group Antigens | 1 | 1989 | 11 |
Why?
| Sheep | 1 | 1989 | 47 |
Why?
| Motor Activity | 1 | 2010 | 104 |
Why?
| Receptors, sigma | 1 | 1989 | 2 |
Why?
| Synaptic Membranes | 1 | 1989 | 4 |
Why?
| Antigen-Antibody Complex | 2 | 1985 | 34 |
Why?
| Neural Pathways | 1 | 2010 | 48 |
Why?
| Phenol | 1 | 2008 | 3 |
Why?
| Cations, Monovalent | 1 | 1988 | 13 |
Why?
| Lithium | 1 | 1988 | 28 |
Why?
| Microdialysis | 1 | 2008 | 6 |
Why?
| Subcellular Fractions | 1 | 1988 | 67 |
Why?
| Phosphorylation | 2 | 1980 | 224 |
Why?
| Oxidation-Reduction | 1 | 1989 | 124 |
Why?
| Biotransformation | 1 | 2008 | 25 |
Why?
| Iodine Radioisotopes | 1 | 1988 | 64 |
Why?
| Nerve Tissue Proteins | 1 | 1990 | 128 |
Why?
| Xylose | 1 | 2007 | 8 |
Why?
| Lactose | 1 | 2007 | 10 |
Why?
| Rats, Inbred F344 | 1 | 2008 | 80 |
Why?
| Mice, Transgenic | 1 | 2010 | 209 |
Why?
| Potassium | 1 | 1988 | 98 |
Why?
| Glycosylation | 1 | 2007 | 37 |
Why?
| Glycine | 1 | 2007 | 40 |
Why?
| Inhibitory Concentration 50 | 1 | 2006 | 12 |
Why?
| Polyamines | 1 | 2006 | 6 |
Why?
| Cell Fusion | 2 | 1983 | 19 |
Why?
| Nervous System | 1 | 1987 | 52 |
Why?
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2006 | 6 |
Why?
| beta-Adrenergic Receptor Kinases | 1 | 2006 | 8 |
Why?
| Immunoglobulin kappa-Chains | 1 | 1986 | 14 |
Why?
| Serine | 1 | 2007 | 62 |
Why?
| Water | 1 | 2007 | 85 |
Why?
| Ileum | 1 | 2006 | 33 |
Why?
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2006 | 14 |
Why?
| Protein Interaction Mapping | 1 | 2006 | 19 |
Why?
| HL-60 Cells | 1 | 2006 | 28 |
Why?
| Immunoglobulin G | 2 | 1985 | 192 |
Why?
| Diprenorphine | 1 | 1985 | 1 |
Why?
| Flunitrazepam | 1 | 1985 | 1 |
Why?
| Quinuclidinyl Benzilate | 1 | 1985 | 3 |
Why?
| Gene Library | 1 | 2006 | 50 |
Why?
| GTP-Binding Protein alpha Subunits | 1 | 2006 | 6 |
Why?
| Tissue Distribution | 2 | 1981 | 124 |
Why?
| Biological Assay | 1 | 2006 | 58 |
Why?
| Immunoglobulin Light Chains | 1 | 1985 | 10 |
Why?
| Membrane Fusion | 1 | 2005 | 17 |
Why?
| Cysteine | 1 | 1986 | 52 |
Why?
| Software | 1 | 2006 | 92 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 67 |
Why?
| Estradiol | 1 | 2005 | 78 |
Why?
| Formates | 1 | 2004 | 1 |
Why?
| Glucose | 1 | 2007 | 120 |
Why?
| Methylation | 1 | 2004 | 36 |
Why?
| RNA, Small Interfering | 1 | 2005 | 116 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 224 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 1981 | 168 |
Why?
| Immunologic Techniques | 1 | 1984 | 19 |
Why?
| Receptors, CCR5 | 1 | 2004 | 10 |
Why?
| Computer Simulation | 1 | 2006 | 134 |
Why?
| Vomiting | 1 | 2004 | 45 |
Why?
| Hydrogen Bonding | 1 | 2004 | 24 |
Why?
| DNA, Viral | 1 | 2005 | 98 |
Why?
| Hypnotics and Sedatives | 1 | 2004 | 45 |
Why?
| Phospholipases | 1 | 1983 | 6 |
Why?
| Benzamides | 1 | 2002 | 11 |
Why?
| Membrane Lipids | 1 | 1983 | 23 |
Why?
| Peptide Hydrolases | 1 | 1983 | 38 |
Why?
| Antibodies, Viral | 1 | 2005 | 104 |
Why?
| Ca(2+) Mg(2+)-ATPase | 1 | 1982 | 11 |
Why?
| Erythrocyte Membrane | 1 | 1983 | 26 |
Why?
| Calcium-Transporting ATPases | 1 | 1982 | 17 |
Why?
| Piperazines | 1 | 2002 | 57 |
Why?
| Protein Conformation | 2 | 1990 | 123 |
Why?
| Torpedo | 1 | 1981 | 1 |
Why?
| Drug Antagonism | 1 | 1981 | 4 |
Why?
| Neurotransmitter Agents | 1 | 1981 | 30 |
Why?
| Octoxynol | 1 | 1980 | 8 |
Why?
| Heart Ventricles | 1 | 1982 | 86 |
Why?
| Psychotropic Drugs | 1 | 1981 | 30 |
Why?
| Chymotrypsin | 1 | 1980 | 10 |
Why?
| Phosphatidylethanolamines | 1 | 1980 | 11 |
Why?
| Phosphatidylserines | 1 | 1980 | 13 |
Why?
| Polyethylene Glycols | 1 | 1980 | 45 |
Why?
| Phospholipases A | 1 | 1980 | 24 |
Why?
| Fishes | 1 | 1980 | 20 |
Why?
| Ganglia, Spinal | 1 | 1999 | 21 |
Why?
| Membrane Potentials | 1 | 1999 | 99 |
Why?
| Amino Acid Substitution | 1 | 1998 | 68 |
Why?
| Calcium Channels | 1 | 1999 | 52 |
Why?
| Mutagenesis, Site-Directed | 1 | 1998 | 126 |
Why?
| Isocitrate Dehydrogenase | 1 | 1976 | 4 |
Why?
| Metamorphosis, Biological | 1 | 1976 | 4 |
Why?
| Open Reading Frames | 1 | 1996 | 56 |
Why?
| Malate Dehydrogenase | 1 | 1976 | 9 |
Why?
| Radioimmunoassay | 2 | 1985 | 82 |
Why?
| Catalase | 1 | 1976 | 27 |
Why?
| Adolescent | 1 | 2005 | 892 |
Why?
| DNA, Complementary | 1 | 1996 | 139 |
Why?
| Fetus | 1 | 1996 | 105 |
Why?
| Species Specificity | 1 | 1976 | 186 |
Why?
| Acetylation | 1 | 1995 | 46 |
Why?
| Muscle, Smooth | 1 | 1995 | 69 |
Why?
| Codeine | 1 | 1993 | 3 |
Why?
| Adult | 2 | 1985 | 1321 |
Why?
| Neoplasm Proteins | 1 | 1995 | 110 |
Why?
| Glutamates | 1 | 1990 | 29 |
Why?
| Oligonucleotide Probes | 1 | 1990 | 40 |
Why?
| Aspartic Acid | 1 | 1990 | 37 |
Why?
| Chromatography, High Pressure Liquid | 1 | 1990 | 122 |
Why?
| Glutamic Acid | 1 | 1990 | 66 |
Why?
| Aging | 1 | 1976 | 275 |
Why?
| Cloning, Molecular | 1 | 1990 | 183 |
Why?
| Hydrogen-Ion Concentration | 1 | 1990 | 176 |
Why?
| Immunoglobulin lambda-Chains | 1 | 1986 | 11 |
Why?
| Communicable Diseases | 1 | 1986 | 22 |
Why?
| Complement Activating Enzymes | 1 | 1985 | 2 |
Why?
| Complement C1q | 1 | 1985 | 8 |
Why?
| Liver | 1 | 1990 | 249 |
Why?
| DNA | 1 | 1990 | 263 |
Why?
| Nervous System Diseases | 1 | 1986 | 78 |
Why?
| Antibodies | 1 | 1985 | 159 |
Why?
| Freezing | 1 | 1984 | 26 |
Why?
| Ascitic Fluid | 1 | 1984 | 20 |
Why?
| Gonadotropin-Releasing Hormone | 1 | 1984 | 23 |
Why?
| Inflammation | 1 | 1986 | 208 |
Why?
|
|
Bidlack's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
